Litcius/Paper detail

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

Alessandro Russo, Marco Russano, Tindara Franchina, Maria Rita Migliorino, Giuseppe Aprile, Giovanni Mansueto, Alfredo Berruti, Alfredo Falcone, Michele Aieta, Alain Gelibter, Antonio Russo, Sandro Barni, Michele Maio, Olga Martelli, Francesco Pantano, Daniela Iacono, Lorenzo Calvetti, Silvia Quadrini, Elisa Roca, Enrico Vasile, Marco Imperatori, Mario Occhipinti, Antonio Galvano, Fausto Petrelli, Luana Calabrò, G. Pasquini, Salvatore Intagliata, Giuseppina Rosaria Rita Ricciardi, Giuseppe Tonini, Daniele Santini, Vincenzo Adamo

2020Advances in Therapy168 citationsDOI

Topics & Concepts

MedicineNivolumabInternal medicineLung cancerLactate dehydrogenaseNeutrophil to lymphocyte ratioLymphocyteRetrospective cohort studyOncologynon-small cell lung cancer (NSCLC)GastroenterologyCancerImmunotherapyChemistryEnzymeA549 cellBiochemistryInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical Imaging